AP
Anthony Petrone Mizuho Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Alcon
ALC
$38.9B
| $78.72 | $110 |
40%
upside
| Outperform | 13 days ago |
|
2
Haemonetics
HAE
$2.57B
| $53.28 | $70 |
31%
upside
| Outperform | 27 days ago |
|
3
Lantheus
LNTH
$3.75B
| $55.15 | $70 |
27%
upside
| Outperform | 28 days ago |
|
4
ResMed
RMD
$39.4B
| $269.21 | $290 |
8%
upside
| Outperform | 1 month ago |
|
5
Teleflex
TFX
$5.57B
| $126.05 | $135 |
7%
upside
| Neutral | 1 month ago |
|
6
Edwards Lifesciences
EW
$47.7B
| $81.22 | $95 |
17%
upside
| Outperform | 1 month ago |
|
7
Abbott
ABT
$230B
| $132.18 | $135 |
2%
upside
| Neutral | 1 month ago |
|
8
Cooper Companies
COO
$13.3B
| $67.14 | $90 |
34%
upside
| Outperform | 1 month ago |
|
9
STAAR Surgical
STAA
$1.35B
| $27.32 | $18 |
34%
downside
| Neutral | 1 month ago |
|
10
Medtronic
MDT
$118B
| $92.25 | $100 |
8%
upside
| Outperform | 1 month ago |
|
11
Hologic
HOLX
$14.7B
| $66.24 | $70 |
6%
upside
| Outperform | 1 month ago |
|
12
Establishment Labs
ESTA
$1.11B
| $38.37 | $70 |
82%
upside
| Outperform | 1 month ago |
|
13
Embecta
EMBC
$837M
| $14.31 | $12 |
16%
downside
| Neutral | 1 month ago |
|
14
DexCom
DXCM
$30.9B
| $78.92 | $100 |
27%
upside
| Outperform | 1 month ago |
|
15
Guardant Health
GH
$8.11B
| $65.06 | $65 |
0%
downside
| Outperform | 2 months ago |
|
16
Glaukos
GKOS
$5.42B
| $94.47 | $175 |
85%
upside
| Outperform | 4 months ago |
|
17
Senseonics Holdings
SENS
$368M
| $0.4520 | $2 |
342%
upside
| Outperform | 4 months ago |
|
18
Tandem Diabetes Care
TNDM
$834M
| $12.35 | $20 |
62%
upside
| Neutral | 4 months ago |
|
19
Exact Sciences
EXAS
$9.33B
| $49.27 | $60 |
22%
upside
| Outperform | 4 months ago |
|
20
Tarsus Pharmaceuticals
TARS
$2.44B
| $57.72 | $58 |
0%
upside
| Buy | 6 months ago |
|
21
LivaNova
LIVN
$3.09B
| $56.59 | $60 |
6%
upside
| Outperform | 6 months ago |
|
22
Boston Scientific
BSX
$159B
| $107.53 | $110 |
2%
upside
| Outperform | 10 months ago |
|
23
ADMA Biologics
ADMA
$4.03B
| $16.90 | $14 |
17%
downside
| Buy | 1 year ago |
|
|
24
Alcon
ALC
$38.9B
| $78.72 | $105 |
33%
upside
| Buy | 1 year ago |
|
25
GE HealthCare
GEHC
$33B
| $72.38 | $105 |
45%
upside
| Buy | 1 year ago |
|